We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0RKL market cap is 3.34B. The company's latest EPS is SEK 2.9150 and P/E is 36.36.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Revenue | 220.84M | 179.86M | 258.39M | 415.29M | 597.54M |
Operating Income | 3.97M | -44.19M | -18.74M | 4.46M | 5.4M |
Net Income | 4.94M | -43.74M | 8.15M | 18.43M | 91.82M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Assets | 634.49M | 1.15B | 1.54B | 1.73B | 2.2B |
Total Liabilities | 56.97M | 141.85M | 257.15M | 302.95M | 250.57M |
Total Equity | 577.52M | 1.01B | 1.29B | 1.43B | 1.95B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Operating | 29.51M | -12.27M | -12.06M | 27.86M | 46.29M |
Investing | -83.84M | -266.53M | -187.7M | -197.62M | -161.62M |
Financing | 25.55M | 482.77M | 234.61M | -6.84M | 418.55M |
Market Cap | 3.34B |
Price to Earnings Ratio | 36.36 |
Price to Sales Ratio | 5.59 |
Price to Cash Ratio | 13.57 |
Price to Book Ratio | 1.72 |
Dividend Yield | - |
Shares Outstanding | 31.5M |
Average Volume (1 week) | 25.77k |
Average Volume (1 Month) | 6.98k |
52 Week Change | 0.00% |
52 Week High | 106.00 |
52 Week Low | 106.00 |
Spread (Intraday) | 0 (0%) |
Company Name | Xvivo Perfusion Ab |
Address |
massans gata 10 goteborg SE-400 14 |
Website | https://www.xvivoperfusion.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions